Income Statement OncoSil Medical Limited

Equities

OSL

AU000000OSL3

Pharmaceuticals

Delayed Australian S.E. Other stock markets 10:20:03 2024-09-09 pm EDT			5-day change	1st Jan Change
0.0130 ^AUD	0.00%		+8.33%	+44.44%

Aug. 30	OncoSil Medical Limited Appoints Peter Hall as Non-Executive Director	CI
Aug. 30	OncoSil Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2024	CI

f72b5e0158c9befc818c4.NC5Oi-0zirN6amDzRHgY4V59PyOJ4P3O7m_EEzLFm4Q.Q2Mj8qZn28otAFWlEjZUgicwcU7llrz9nQSKeWGw3v5VFwK4jHC7_CkmMQ

Published financial data: ONCOSIL MEDICAL LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2019	2020	2021	2022	2023
Revenues	-	-	213K	232K	368K
Other Revenues, Total	3.63M	2.76M	1.09M	832K	1.1M
Total Revenues	3.63M	2.76M	1.3M	1.06M	1.47M
Cost of Goods Sold, Total	-	-	961K	972K	1.59M
Gross Profit	3.63M	2.76M	337K	90.91K	-121K
Selling General & Admin Expenses, Total	6.84M	3.48M	7.99M	8.29M	8.36M
Stock-Based Compensation (IS)	-	-	-	-	-
R&D Expenses	5.58M	3.73M	2.89M	2.38M	2.85M
Other Operating Expenses, Total	12.41M	7.21M	10.88M	10.67M	11.21M
Operating Income	-8.79M	-4.45M	-10.54M	-10.58M	-11.34M
Interest Expense, Total	-	-11.08K	-15.75K	-19.62K	-10.9K
Interest And Investment Income	204K	105K	82.48K	10.13K	62.61K
Net Interest Expenses	204K	93.8K	66.74K	-9.49K	51.71K
Currency Exchange Gains (Loss)	14.85K	1.09K	-104K	-139K	-59.14K
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-8.57M	-4.35M	-10.58M	-10.73M	-11.34M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Other Unusual Items	-	89K	146K	-	-
EBT, Incl. Unusual Items	-8.57M	-4.26M	-10.43M	-10.73M	-11.34M
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-8.57M	-4.26M	-10.43M	-10.73M	-11.34M
Net Income to Company	-8.57M	-4.26M	-10.43M	-10.73M	-11.34M
Net Income - (IS)	-8.57M	-4.26M	-10.43M	-10.73M	-11.34M
Net Income to Common Incl Extra Items	-8.57M	-4.26M	-10.43M	-10.73M	-11.34M
Net Income to Common Excl. Extra Items	-8.57M	-4.26M	-10.43M	-10.73M	-11.34M
Per Share Items
Net EPS - Basic	-0.01	-0.01	-0.01	-0.01	-0.01
Basic EPS - Continuing Operations	-0.01	-0.01	-0.01	-0.01	-0.01
Basic Weighted Average Shares Outstanding	629M	656M	818M	811M	1.13B
Net EPS - Diluted	-0.01	-0.01	-0.01	-0.01	-0.01
Diluted EPS - Continuing Operations	-0.01	-0.01	-0.01	-0.01	-0.01
Diluted Weighted Average Shares Outstanding	629M	656M	818M	811M	1.13B
Normalized Basic EPS	-0.01	-0	-0.01	-0.01	-0.01
Normalized Diluted EPS	-0.01	-0	-0.01	-0.01	-0.01
Supplemental Items
EBITDA	-8.75M	-4.42M	-10.51M	-10.55M	-11.32M
EBITA	-8.79M	-4.45M	-10.54M	-10.58M	-11.34M
EBIT	-8.79M	-4.45M	-10.54M	-10.58M	-11.34M
EBITDAR	-8.57M	-4.29M	-10.36M	-10.49M	-11.23M
Effective Tax Rate - (Ratio)	-	-	-	-	-
Normalized Net Income	-5.35M	-2.72M	-6.61M	-6.7M	-7.09M
Interest on Long-Term Debt	-	10.22K	14.67K	19.62K	10.9K
Supplemental Operating Expense Items
Marketing Expenses	-	-	685K	370K	130K
Selling and Marketing Expenses	-	-	685K	370K	130K
General and Administrative Expenses	1.53M	2.26M	2.01M	2M	3.05M
Research And Development Expense From Footnotes	5.58M	3.73M	2.89M	2.38M	2.85M
Net Rental Expense, Total	174K	131K	148K	57.85K	83.31K
Imputed Operating Lease Interest Expense	-	-	62.72K	23.04K	30.59K
Imputed Operating Lease Depreciation	-	-	85.23K	34.82K	52.72K
Stock-Based Comp., SG&A Exp. (Total)	1.13M	-2.39M	-141K	593K	386K
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	1.13M	-2.39M	-141K	593K	386K

Fiscal Period: June	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	7.69M	21M	12.24M	11.28M	9.39M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	7.69M	21M	12.24M	11.28M	9.39M
Accounts Receivable, Total	3.78M	2.76M	1.11M	848K	1.16M
Other Receivables	38.19K	42.27K	75.56K	59.64K	125K
Total Receivables	3.82M	2.81M	1.18M	908K	1.29M
Prepaid Expenses	28.39K	48.55K	108K	468K	439K
Other Current Assets, Total	69.21K	69.21K	90.53K	89.27K	117K
Total Current Assets	11.61M	23.92M	13.62M	12.74M	11.23M
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	62.47K	138K	531K	325K	239K
Other Intangibles, Total	-	-	-	-	-
Total Assets	11.67M	24.06M	14.15M	13.07M	11.47M
Liabilities
Accounts Payable, Total	364K	1.36M	1.23M	931K	960K
Accrued Expenses, Total	324K	485K	510K	343K	164K
Short-term Borrowings	-	26.56K	-	-	-
Current Portion of Leases	-	83.38K	163K	165K	146K
Other Current Liabilities	305K	208K	232K	328K	299K
Total Current Liabilities	993K	2.16M	2.13M	1.77M	1.57M
Long-Term Leases	-	-	321K	139K	24.56K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	993K	2.16M	2.45M	1.91M	1.59M
Common Stock, Total	52.26M	70.14M	70.4M	79.91M	86.51M
Retained Earnings	-47.6M	-51.86M	-62.3M	-73.02M	-84.37M
Comprehensive Income and Other	6.02M	3.63M	3.6M	4.28M	7.74M
Total Common Equity	10.68M	21.9M	11.7M	11.16M	9.88M
Total Equity	10.68M	21.9M	11.7M	11.16M	9.88M
Total Liabilities And Equity	11.67M	24.06M	14.15M	13.07M	11.47M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	631M	829M	797M	991M	1.98B
ECS Total Common Shares Outstanding	631M	829M	797M	991M	1.98B
Book Value / Share	0.02	0.03	0.01	0.01	0
Tangible Book Value	10.68M	21.9M	11.7M	11.16M	9.88M
Tangible Book Value Per Share	0.02	0.03	0.01	0.01	0
Total Debt	0	110K	484K	304K	171K
Net Debt	-7.69M	-20.89M	-11.76M	-10.98M	-9.22M
Debt Equivalent Oper. Leases	1.39M	1.05M	1.18M	463K	666K
Account Code - Inventory Valuation	3	3	3	-	-
Machinery, Total	-	-	-	-	-

Fiscal Period: June	2019	2020	2021	2022	2023
Net Income	-8.57M	-4.26M	-10.43M	-10.73M	-11.34M
Depreciation & Amortization - CF	38.62K	149K	185K	192K	176K
Depreciation & Amortization, Total	38.62K	149K	185K	192K	176K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	1.13M	-2.39M	-141K	593K	386K
Other Operating Activities, Total	-45.93K	-1.13K	109K	87.37K	-2.56K
Change In Accounts Receivable	-	-	-28.69K	274K	-378K
Change In Accounts Payable	-816K	1.01M	-49.32K	-74.31K	-78.54K
Change in Other Net Operating Assets	756K	1.04M	1.54M	-455K	-75.17K
Cash from Operations	-7.5M	-4.46M	-8.82M	-10.11M	-11.32M
Capital Expenditure	-14.83K	-20.72K	-54K	-5.83K	-57.82K
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-14.83K	-20.72K	-54K	-5.83K	-57.82K
Short Term Debt Issued, Total	-	26.56K	-	-	-
Total Debt Issued	-	26.56K	-	-	-
Short Term Debt Repaid, Total	-	-	-26.56K	-	-
Long-Term Debt Repaid, Total	-	-121K	-122K	-160K	-187K
Total Debt Repaid	-	-121K	-149K	-160K	-187K
Issuance of Common Stock	-	19.04M	-	9.32M	6.6M
Other Financing Activities, Total	-	-1.16M	260K	-	3.08M
Cash from Financing	-	17.79M	111K	9.16M	9.49M
Net Change in Cash	-7.52M	13.31M	-8.76M	-960K	-1.89M
Supplemental Items
Cash Interest Paid	-	11.08K	15.75K	19.62K	10.9K
Cash Income Tax Paid (Refund)	-4.29M	-3.72M	-2.76M	-832K	-821K
Levered Free Cash Flow	-4.39M	-3M	-5.14M	-6.3M	-7.14M
Unlevered Free Cash Flow	-4.39M	-2.99M	-5.13M	-6.28M	-7.14M
Change In Net Working Capital	60.2K	-2.05M	-1.46M	452K	556K
Net Debt Issued / Repaid	-	-94.53K	-149K	-160K	-187K

Fiscal Period: June	2019	2020	2021	2022	2023
Profitability
Return on Assets	-34.81	-15.55	-34.49	-48.58	-57.73
Return on Total Capital	-38.09	-17	-38.54	-55.91	-65.85
Return On Equity %	-59.43	-26.17	-62.11	-93.85	-107.81
Return on Common Equity	-59.43	-26.17	-62.11	-93.85	-107.81
Margin Analysis
Gross Profit Margin %	100	100	25.98	8.55	-8.27
SG&A Margin	188.51	126.03	615.52	779.79	569.92
EBITDA Margin %	-241.23	-159.89	-809.41	-991.98	-771.1
EBITA Margin %	-242.29	-160.86	-811.96	-994.72	-772.48
EBIT Margin %	-242.29	-160.86	-811.96	-994.72	-772.48
Income From Continuing Operations Margin %	-236.25	-154.2	-803.61	-1.01K	-772.98
Net Income Margin %	-236.25	-154.2	-803.61	-1.01K	-772.98
Net Avail. For Common Margin %	-236.25	-154.2	-803.61	-1.01K	-772.98
Normalized Net Income Margin	-147.66	-98.39	-509.29	-630.46	-483.11
Levered Free Cash Flow Margin	-121.19	-108.52	-396.19	-592.09	-486.82
Unlevered Free Cash Flow Margin	-121.19	-108.27	-395.43	-590.93	-486.36
Asset Turnover
Asset Turnover	0.23	0.15	0.07	0.08	0.12
Fixed Assets Turnover	48.76	27.52	3.88	2.49	5.2
Receivables Turnover (Average Receivables)	-	-	0.11	0.24	0.37
Short Term Liquidity
Current Ratio	11.69	11.08	6.39	7.21	7.16
Quick Ratio	11.59	11.03	6.29	6.89	6.81
Operating Cash Flow to Current Liabilities	-7.55	-2.06	-4.13	-5.72	-7.21
Days Sales Outstanding (Average Receivables)	-	-	3.31K	1.54K	997.23
Average Days Payable Outstanding	-	-	490.43	404.98	217.24
Long Term Solvency
Total Debt/Equity	-	0.5	4.14	2.73	1.73
Total Debt / Total Capital	-	0.5	3.98	2.65	1.7
LT Debt/Equity	-	-	2.75	1.24	0.25
Long-Term Debt / Total Capital	-	-	2.64	1.21	0.24
Total Liabilities / Total Assets	8.51	8.97	17.34	14.59	13.89
EBIT / Interest Expense	-	-401.06	-669.45	-539.02	-1.04K
EBITDA / Interest Expense	-	-387.6	-657.72	-529.25	-1.02K
(EBITDA - Capex) / Interest Expense	-	-389.46	-661.15	-529.54	-1.03K
Total Debt / EBITDA	-	-0.03	-0.05	-0.03	-0.02
Net Debt / EBITDA	0.88	4.86	1.14	1.06	0.83
Total Debt / (EBITDA - Capex)	-	-0.03	-0.05	-0.03	-0.02
Net Debt / (EBITDA - Capex)	0.88	4.84	1.13	1.06	0.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-18.47	-23.78	-53.02	-18.1	38
Gross Profit, 1 Yr. Growth %	-18.47	-23.78	-87.8	-73.05	-233.48
EBITDA, 1 Yr. Growth %	1.69	-49.48	138.57	0.38	7.27
EBITA, 1 Yr. Growth %	1.67	-49.4	137.89	0.34	7.16
EBIT, 1 Yr. Growth %	1.67	-49.4	137.89	0.34	7.16
Earnings From Cont. Operations, 1 Yr. Growth %	0.32	-50.25	144.81	2.81	5.74
Net Income, 1 Yr. Growth %	0.32	-50.25	144.81	2.81	5.74
Normalized Net Income, 1 Yr. Growth %	0.31	-49.21	143.16	1.39	5.74
Diluted EPS Before Extra, 1 Yr. Growth %	-17.89	-52.32	96.95	3.36	-24.1
Accounts Receivable, 1 Yr. Growth %	-14.86	-26.91	-59.98	-23.31	36.89
Net Property, Plant and Equip., 1 Yr. Growth %	-27.58	121.52	283.59	-38.78	-26.37
Total Assets, 1 Yr. Growth %	-41.31	106.2	-41.19	-7.64	-12.21
Tangible Book Value, 1 Yr. Growth %	-41.2	105.16	-46.59	-4.56	-11.49
Common Equity, 1 Yr. Growth %	-41.2	105.16	-46.59	-4.56	-11.49
Cash From Operations, 1 Yr. Growth %	-10.67	-40.59	97.83	14.69	11.92
Capital Expenditures, 1 Yr. Growth %	38.63	39.74	160.61	-89.2	891.41
Levered Free Cash Flow, 1 Yr. Growth %	-16.02	-31.75	71.5	22.4	13.46
Unlevered Free Cash Flow, 1 Yr. Growth %	-16.02	-31.9	72.08	22.4	13.57
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.58	-21.17	-40.16	-37.97	6.31
Gross Profit, 2 Yr. CAGR %	1.58	-21.17	-69.5	-81.86	-40.02
EBITDA, 2 Yr. CAGR %	9.72	-28.32	9.61	54.75	3.77
EBITA, 2 Yr. CAGR %	9.74	-28.27	9.54	54.5	3.7
EBIT, 2 Yr. CAGR %	9.74	-28.27	9.54	54.5	3.7
Earnings From Cont. Operations, 2 Yr. CAGR %	10.5	-29.35	10.36	58.65	4.27
Net Income, 2 Yr. CAGR %	10.5	-29.35	10.36	58.65	4.27
Normalized Net Income, 2 Yr. CAGR %	9.94	-28.62	11.13	57.02	3.55
Diluted EPS Before Extra, 2 Yr. CAGR %	-4.38	-37.43	-3.09	42.68	-11.43
Accounts Receivable, 2 Yr. CAGR %	4.74	-21.12	-45.92	-44.6	2.46
Net Property, Plant and Equip., 2 Yr. CAGR %	-26.45	26.66	191.5	53.24